Dextromethorphan/quinidine for treatment of pseudobulbar affect (PBA) in patients with dementia: Examination of CNS-LS outcomes in a 12-week openlabel trial (PRISM II)

Authors
Category Primary study
JournalAlzheimer's and Dementia
Year 2015
This article has no abstract
Epistemonikos ID: 0b2186f326cf84ee82b227cb6adf18aef41ae132
First added on: Feb 07, 2025